Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatEU pharma sector inquiry -- the IPI response
By Johanna Gibson, David Pearce, Jeremy Phillips and Ilanah Simon.
ADVERTISEMENTS
Right: the IPKat has his own opinion about pharmaceutical products, but for once he's keeping his mouth shut.
STOP PRESS: the IPKat has just received the response of the Intellectual Property Lawyers' Association (IPLA) to the same Inquiry. You can read the IPLA response here.
Full post as published by IPKat on February 05, 2009 (boomark / email).
Lawsuits and Settlements
Medical Records
To Stay out of Pharma's Hands
Hormone Replacement Therapy Lawsuits See Multi-Million Dollar Settlements
HRT Lawsuits Pharma Faces Multi Million Dollar Settlements
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

C5 "EU Pharma Law and Regulation" Conference, Geneva, November 4-5
European Commission's Pharmaceutical Sector Inquiry
EU Thinks Pharma Deliberately Blocked Generics
C5 Pharma/Biotech Patent Litigation Conference
European Commission Releases Preliminary Report on Competition in Pharmaceutical Sector








